Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Cited by (1,093)

Items 401–500 of 1,093

1. Protective Factors and the Pathogenesis of Complications in Diabetes
   Marc Gregory Yu, Daniel Gordin, Jialin Fu, Kyoungmin Park, Qian Li, George Liang King · 2023 · Endocrine Reviews
2. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
   Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, Guy De Backer (Belgium), Helmut Gohlke (Germany), Ian Graham (Ireland), Željko Reiner (Croatia), WM Monique Verschuren (The Netherlands), Christian Albus (Germany), Pascale Benlian (France), Gudrun Boysen (Denmark), Renata Cifkova (Czech Republic), Christi Deaton (UK), Shah Ebrahim (UK), Miles Fisher (UK), Giuseppe Germano (Italy), Richard Hobbs (UK), Arno Hoes (The Netherlands), Sehnaz Karadeniz (Turkey), Alessandro Mezzani (Italy), Eva Presco · 2012 · European Journal of Preventive Cardiology
3. Drug safety assessment in clinical trials: methodological challenges and opportunities
   Sonal Singh, Yoon Kong Loke · 2012 · Trials
4. Intensive glucose control in patients with type 2 diabetes - 15-year follow-up.
   Reaven, Peter D., Emanuele, Nicholas V., Wiitala, Wyndy L., Bahn, Gideon D., Reda, Domenic J., McCarren, Madeline, Duckworth, William C., Hayward, Rodney A. · 2019 · New England Journal of Medicine
5. Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials
   Wang, B., Zhong, J., Lin, H., Zhao, Z., Yan, Z., He, H., Ni, Y., Liu, D., Zhu, Z. · 2013 · Diabetes, Obesity and Metabolism
6. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes
   Christopher James Nolan, Neil B. Ruderman, Steven E. Kahn, Oluf Borbye Pedersen, Marc Prentki · 2015 · Diabetes
7. Diabetes and Aging: unique considerations and goals of care
   Kalyani, Rita R., Golden, Sherita H., Cefalu, William T. · 2017 · Diabetes Care
8. Pioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes
   DeFronzo, Ralph A, Inzucchi, Silvio, Abdul-Ghani, Muhammad, Nissen, Steven E · 2019 · Diabetes and Vascular Disease Research
9. Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal Transplantation
   Manfred Hecking, Michael Haidinger, Dominik Döller, Johannes M. Werzowa, Andrea Tura, Jinyao Zhang, Hilal Tekoglu, Johannes Pleiner, Thomas Wrba, Susanne Rasoul‐Rockenschaub et al. · 2012 · Journal of the American Society of Nephrology
10. Tissue Factor, Blood Coagulation, and Beyond: An Overview
    Arthur J. Chu · 2011 · International Journal of Inflammation
11. Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study
    Angus Forbes, Trevor Murrells, Henrietta E. Mulnier, Alan J. Sinclair · 2018 · The Lancet Diabetes & Endocrinology
12. Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial
    Tay, Jeannie, Thompson, Campbell H., Luscombe‐Marsh, Natalie D., Wycherley, Thomas P., Noakes, Manny, Buckley, Jonathan D., Wittert, Gary A., Yancy, William S., Brinkworth, Grant D. · 2018 · Diabetes, Obesity and Metabolism
13. Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study
    de Pablos‐Velasco, Pedro, Parhofer, Klaus G, Bradley, Clare, Eschwège, Eveline, Gönder-Frederick, Linda, Maheux, Pierre, Wood, Ian, Simon, Dominique · 2014 · Clinical Endocrinology
14. Large and Small Artery Cross-Talk and Recent Morbidity-Mortality Trials in Hypertension
    Laurent, Stéphane, Briet, Marie, Boutouyrie, Pierre · 2009 · Hypertension
15. Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment
    Akif Serhat Balcıoğlu · 2015 · World Journal of Diabetes
16. Mortality risk among sulfonylureas: a systematic review and network meta-analysis
    Scot H. Simpson, Jayson Lee, Sabina Choi, Ben Vandermeer, Ahmed S Abdelmoneim, Travis R Featherstone · 2014 · The Lancet Diabetes & Endocrinology
17. Disorders of lipid metabolism. Clinical Guidelines 2023
    Ежов Марат Владиславович, Valery V. Kukharchuk, И. В. Сергиенко, Asiiat S. Alieva, Mikhail Borisovich Antsiferov, Alexey A. Ansheles, Gurami G. Arabidze, Aronov Dm, G. P. Arutyunov, Н. М. Ахмеджанов et al. · 2023 · Russian Journal of Cardiology
18. Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults
    Jerome L. Fleg, Daniel E. Forman, Kathy A. Berra, Vera Bittner, James A. Blumenthal, Michael A. Chen, Susan C. Cheng, Dalane W. Kitzman, Mathew S. Maurer, Michael W. Rich et al. · 2013 · Circulation
19. Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
    Odd Erik Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Dhanji Patel, Hans‐Juergen Woerle · 2012 · Cardiovascular Diabetology
20. American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement
    Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel E. Dagogo-Jack, Michael Davidson, DANIEL F. EINHORN, William Timothy Garvey et al. · 2013 · Endocrine Practice
21. Chronic Hyperglycemia and Glucose Toxicity: Pathology and Clinical Sequelae
    Carlos Campos · 2012 · Postgraduate Medicine
22. A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes
    Robert C. Frederich, John Hunter Alexander, Fred T. Fiedorek, Mark Donovan, Niklas Berglind, Susan Harris, Roland K. Chen, Robert Wolf, Kenneth W. Mahaffey · 2010 · Postgraduate Medicine
23. Cardiovascular disease in diabetes, beyond glucose
    Robert H. Eckel, Karin Bornfeldt, Ira J. Goldberg · 2021 · Cell Metabolism
24. 5. Glycemic Targets
    American Diabetes Association · 2015 · Diabetes Care
25. Epigenetics
    Mark E. Cooper, Assam El‐Osta · 2010 · Circulation Research
26. Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus
    Jun Hata, Hisatomi Arima, Peter Malcolm Rothwell, Mark Woodward, Sophia Zoungas, Craig S. Anderson, Anushka A Patel, Bruce Charles Neal, Paul Glasziou, Pavel Hamet et al. · 2013 · Circulation
27. Coronary Artery Disease and Diabetes Mellitus
    Aronson, Doron, Edelman, Elazer R. · 2014 · Cardiology Clinics
28. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes
    Papademetriou, Vasilios, Lovato, Laura, Doumas, Michael, Nylen, Eric, Mottl, Amy, Cohen, Robert M., Applegate, William B., Puntakee, Zubin, Yale, Jean Francois, Cushman, William C. · 2015 · Kidney International
29. Minimizing Hypoglycemia in Diabetes
    International Hypoglycaemia Study Group · 2015 · Diabetes Care
30. Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update
    Liping Liu, Zixiao Li, Hongyu Zhou, Wanying Duan, Xiaochuan Huo, Weihai Xu, Shujuan Li, Ximing Nie, Huihui Liu, Jinjie Liu et al. · 2023 · Stroke and Vascular Neurology
31. Diabetes and Altered Glucose Metabolism with Aging
    Rita Rastogi Kalyani, Josephine Mary Egan · 2013 · Endocrinology and Metabolism Clinics of North America
32. Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015
    Νικόλαος Παπάνας, Dan Ziegler · 2015 · The Review of Diabetic Studies
33. Endothelial Dysfunction and Diabetic Cardiomyopathy
    Moran Wang, Yongsheng Li, Sheng Li, Jiagao Lv · 2022 · Frontiers in Endocrinology
34. Abnormal Hepatic Energy Homeostasis in Type 2 Diabetes†
    Szendroedi, Julia, Chmelik, Marek, Schmid, Albrecht Ingo, Nowotny, Peter, Brehm, Attila, Krssak, Martin, Moser, Ewald, Roden, Michael · 2009 · Hepatology
35. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study
    Lachin, John M., Orchard, Trevor J., Nathan, David M., for the DCCT/EDIC Research Group · 2014 · Diabetes Care
36. Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
    Priscilla A. Hollander, Jia Li, Elsie Allen, Roland K. Chen, for the CV181-013 Investigators · 2009 · The Journal of Clinical Endocrinology & Metabolism
37. Link between the renin–angiotensin system and insulin resistance: Implications for cardiovascular disease
    Ming-Sheng Zhou, Ivonne Hernandez Schulman, Qiang Zeng · 2012 · Vascular Medicine
38. Improved Glycemic Control Without Hypoglycemia in Elderly Diabetic Patients Using the Ubiquitous Healthcare Service, a New Medical Information System
    Lim, Soo, Kang, Seon Mee, Shin, Hayley, Lee, Hak Jong, Won Yoon, Ji, Yu, Sung Hoon, Kim, So-Youn, Yoo, Soo Young, Jung, Hye Seung, Park, Kyong Soo et al. · 2011 · Diabetes Care
39. Cardiovascular disease in chronic kidney disease: untying the Gordian knot
    Reza Hajhosseiny, Kaivan Khavandi, David J.A. Goldsmith · 2012 · International Journal of Clinical Practice
40. Glucose, Obesity, Metabolic Syndrome, and Diabetes
    Tamara B. Horwich, Gregg C. Fonarow · 2010 · Journal of the American College of Cardiology
41. Glycemic Monitoring and Management in Advanced Chronic Kidney Disease
    Rodolfo Javier Galindo, Roy W. Beck, Maria Florencia Scioscia, Guillermo E. Umpierrez, Katherine R. Tuttle · 2020 · Endocrine Reviews
42. 6. Glycemic Targets
    American Diabetes Association · 2015 · Diabetes Care
43. Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
    Robert R. Henry, Abraham Michael Lincoff, Sunder Raj D. Mudaliar, Michael A. Rabbia, Cathy Chognot, Matthias Herz · 2009 · The Lancet
44. Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
    Newman, Jonathan D., Schwartzbard, Arthur Z., Weintraub, Howard S., Goldberg, Ira J., Berger, Jeffrey S. · 2017 · Journal of the American College of Cardiology
45. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
    Bianca Hemmingsen, Søren Søgaard Lund, Christian Nyfeldt Gluud, Allan Arthur Vaag, Thomas Almdal, Jørn Wetterslev · 2013 · Cochrane Database of Systematic Reviews · Retracted
46. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: A meta-analysis of randomized clinical trials
    Edoardo Mannucci, Matteo Monami, Caterina Lamanna, F. Gori, Niccolò Marchionni · 2009 · Nutrition Metabolism and Cardiovascular Diseases
47. Diabetic Kidney Disease: Challenges, Advances, and Opportunities
    Ya Chen, Kyung Lee, Zhaohui Ni, Cijiang He · 2020 · Kidney Diseases
48. Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes
    Amelia Charlton, Jessica Garzarella, Karin Agnes Maria Jandeleit-Dahm, Jay C. Jha · 2020 · Biology
49. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition
    Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova, Alexander Yur'evich Mayorov, Ol'ga Konstantinovna Vikulova, Gagik Radikovich Galstyan, Тамара Леонидовна Кураева, Valentina Aleksandrovna Peterkova, Olga Mikhailovna Smirnova, Elena Georgievna Starostina, Elena Viktorovna Surkova et al. · 2017 · Diabetes Mellitus
50. Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
    Yoshifumi Saisho · 2014 · International Journal of Molecular Sciences
51. Cardiovascular Disease Risk Factors in Youth With Diabetes Mellitus
    David M. Maahs, Stephen R. Daniels, Sarah D. de Ferranti, Helén L. Dichek, Joseph T. Flynn, Benjamin I. Goldstein, Aaron S. Kelly, Kristen J. Nadeau, Pamela A. Martyn-Nemeth, Stavroula K. Osganian et al. · 2014 · Circulation
52. Mitochondrial Hormesis and Diabetic Complications
    Kumar Sharma · 2015 · Diabetes
53. Diabetic kidney disease: from physiology to therapeutics
    Carmen Mora Fernández, V. Domínguez-Pimentel, Mercedes Muros de Fuentes, José Luis Górriz, Alberto Martínez‐Castelao, Juan F. Navarro‐González · 2014 · The Journal of Physiology
54. Lower extremity arterial disease in patients with diabetes: a contemporary narrative review
    Mathilde Nativel, Louis Potier, Laure Alexandre, Laurence Baillet‐Blanco, Eric Ducasse, Gilberto Velho, Michel Marre, Ronan Roussel, Vincent Rigalleau, Kamel Mohammedi · 2018 · Cardiovascular Diabetology
55. The Society for Vascular Surgery implementation document for management of extracranial cerebrovascular disease
    Ali F. AbuRahma, Efthymios D. Avgerinos, Robert W. Chang, Ralph Clement Darling, Audra A. Duncan, Thomas L. Forbes, Mahmoud B. Malas, Bruce Alan Perler, Richard J. Powell, Caron R. Rockman et al. · 2021 · Journal of Vascular Surgery
56. Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes
    The ACCORD Study Group · 2016 · Diabetes Care
57. Combination therapy with <scp>GLP</scp> ‐1 receptor agonist and <scp>SGLT2</scp> inhibitor
    DeFronzo, Ralph A. · 2017 · Diabetes, Obesity and Metabolism
58. Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
    Stephanie M. Toth‐Manikowski, Mohamed G. Atta · 2015 · Journal of Diabetes Research
59. Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
    Miriam Longo, Giuseppe Bellastella, Maria Ida Maiorino, Juris Jendrik Meier, Katherine Esposito, Dario Giugliano · 2019 · Frontiers in Endocrinology
60. Cardiovascular Disease Risk Factors, Type 2 Diabetes Mellitus, and the Framingham Heart Study
    Caroline S. Fox · 2010 · Trends in Cardiovascular Medicine
61. Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies
    Carlo Alberto Ricciardi, Luigi Gnudi · 2021 · Metabolism
62. Glycaemic control in type 2 diabetes: Targets and new therapies
    Abd A. Tahrani, Milan K. Piya, Amy Kennedy, Anthony H Barnett · 2009 · Pharmacology & Therapeutics
63. Cerebrovascular Complications of Diabetes: Focus on Stroke
    Adviye Ergul, Aisha I. Kelly-Cobbs, Maha Abdalla, Susan C. Fagan · 2012 · Endocrine Metabolic & Immune Disorders - Drug Targets
64. Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes
    Joni Ricks, Miklos Zsolt Molnar, Csaba Pal Kovesdy, Anuja Pradip Shah, Allen R. Nissenson, Mark E. Williams, Kamyar Kalantar‐Zadeh · 2012 · Diabetes
65. Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How?
    Edouard L. Fu · 2023 · Journal of the American Society of Nephrology
66. American Geriatrics Society Identifies Five Things That Healthcare Providers and Patients Should Question
    AGS Choosing Wisely Workgroup · 2013 · Journal of the American Geriatrics Society
67. Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy
    Yu Ho Lee, Sang Hoon Kim, Jun Mo Kang, Jin Hyung Heo, Dong-Jin Kim, Seon Hwa Park, Min Ji Sung, Jaehee Kim, Jisu Oh, Dong Ho Yang et al. · 2019 · American Journal of Physiology-Renal Physiology
68. Autonomic Neuropathy in Diabetes Mellitus
    Verrotti, Alberto, Prezioso, Giovanni, Scattoni, Raffaella, Chiarelli, Francesco · 2014 · Frontiers in Endocrinology
69. Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the <scp>E</scp> fficacy and <scp>D</scp> urability of <scp>I</scp> nitial <scp>C</scp> ombination <scp>T</scp> herapy for <scp>T</scp> ype 2 <scp>D</scp> iabetes ( <scp>EDICT</scp> ): a randomized trial
    Abdul‐Ghani, M. A., Puckett, C., Triplitt, C., Maggs, D., Adams, J., Cersosimo, E., DeFronzo, R. A · 2015 · Diabetes, Obesity and Metabolism
70. Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes
    Stephen S. Johnston, Christopher Conner, Mark Aagren, David M. Smith, Jonathan R. Bouchard, Jason Brett · 2011 · Diabetes Care
71. Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis
    Davide Castagno, Jonathan Baird-Gunning, Pardeep S. Jhund, Giuseppe Biondi‐Zoccai, Michael Ross MacDonald, Mark Colquhoun Petrie, Fiorenzo Gaïta, John J.V. McMurray · 2011 · American Heart Journal
72. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial
    Joline W. J. Beulens, Anushka A Patel, Johannes R. Vingerling, John Kennedy Cruickshank, Alun David Hughes, Alice V. Stanton, J. Lu, Simon Thom, Diederick E. Grobbee, Ronald P. Stolk · 2009 · Diabetologia
73. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study
    2014 · The Lancet Diabetes &amp; Endocrinology
74. Comparative Effectiveness of a Mindful Eating Intervention to a Diabetes Self-Management Intervention among Adults with Type 2 Diabetes: A Pilot Study
    Miller, Carla K., Kristeller, Jean L., Headings, Amy, Nagaraja, Haikady, Miser, W. Fred · 2012 · Journal of the Academy of Nutrition and Dietetics
75. Pharmacotherapy of type 2 diabetes: An update
    Jagriti Upadhyay, Stergios A. Pοlyzos, Nikolaos Perakakis, Bindiya Thakkar, Stavroula Α. Paschou, Niki Katsiki, PATRICIA C. UNDERWOOD, Kyung‐Hee Park, Jochen Seufert, Eun Seok Kang et al. · 2017 · Metabolism
76. Precision medicine in the management of type 2 diabetes
    Anna L. Gloyn, Daniel J. Drucker · 2018 · The Lancet Diabetes & Endocrinology
77. Predictors of Remission of Diabetes Mellitus in Severely Obese Individuals Undergoing Bariatric Surgery
    Simona Panunzi, Andrea De Gaetano, Annamaria Carnicelli, Geltrude Mingrone · 2014 · Annals of Surgery
78. Defining Medical Futility and Improving Medical Care
    Lawrence J. Schneiderman · 2011 · Journal of Bioethical Inquiry
79. Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action
    Bartolomeo Lorenzati, Chiara Zucco, Sara Miglietta, Federico Lamberti, Graziella Bruno · 2010 · Pharmaceuticals
80. Active Care Management Supported by Home Telemonitoring in Veterans With Type 2 Diabetes
    Roslyn A. Stone, R Harsha Rao, Mary Ann Sevick, Chunrong Cheng, Linda J. Hough, David S. Macpherson, Carol M. Franko, Rebecca A. Anglin, David Scott Obrosky, Frederick R. DeRubertis · 2009 · Diabetes Care
81. Ctenophore-inspired hydrogels for efficient and repeatable underwater specific adhesion to biotic surfaces
    Xing Su, Yang He Luo, Zhuoling Tian, Zuoying Yuan, Yiming Han, Runfeng Dong, Liang Xu, Yuting Feng, Xiaozhi Liu, Jianyong Huang · 2020 · Materials Horizons
82. Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction
    Tatsuya Maruhashi, Yukihito Higashi · 2021 · Antioxidants
83. A Cascade of Care for Diabetes in the United States: Visualizing the Gaps
    Mohammed Kumail Ali, Kai McKeever Bullard, Edward W. Gregg, Carlos del Rı́o · 2014 · Annals of Internal Medicine
84. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes
    André Pascal Kengne, Anushka A Patel, Michel Marre, Florence Travert, Michel M Lièvre, Sophia Zoungas, John Philip Chalmers, Stephen Colagiuri, Diederick E. Grobbee, Pavel Hamet et al. · 2011 · European Journal of Cardiovascular Prevention & Rehabilitation
85. Guideline for management of postmeal glucose in diabetes
    1 · 2013 · Diabetes Research and Clinical Practice
86. Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
    Peter D. Reaven, THOMAS E. MORITZ, Dawn C. Schwenke, Robert J. Anderson, Michael H. Criqui, Robert Detrano, Nicholas Emanuele, Moti Kayshap, Jennifer B. Marks, Sunder Raj D. Mudaliar et al. · 2009 · Diabetes
87. The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
    Marcel H.A. Muskiet, Mark M. Smits, Linde M. Morsink, Michaëla Diamant · 2013 · Nature Reviews Nephrology
88. Diabetic Kidney Disease
    Ryan Bonner, Oltjon Albajrami, James C. Hudspeth, Ashish Upadhyay · 2020 · Primary Care Clinics in Office Practice
89. Japanese Clinical Practice Guideline for Diabetes 2016
    Masakazu Haneda, Mitsuhiko Noda, Hideki Origasa, Hiroshi Noto, Daisuke Yabe, Yukihiro Fujita, Atsushi Goto, Tatsuya Kondo, Eiichi Araki · 2018 · Journal of Diabetes Investigation
90. 10. Microvascular Complications and Foot Care
    American Diabetes Association · 2016 · Diabetes Care
91. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)
    Eeg‐Olofsson, K., Cederholm, J., Nilsson, P. M., Zethelius, B., Svensson, A.‐M., Gudbjörnsdóttir, S., Eliasson, B. · 2010 · Journal of Internal Medicine
92. Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence
    Rodríguez-Gutiérrez, René, Montori, Victor M. · 2016 · Circulation: Cardiovascular Quality and Outcomes
93. Frailty in elderly diabetes patients
    Toshihiko Yanase, Ikumi Yanagita, Kazuo Muta, Hajime Nawata · 2017 · Endocrine Journal
94. EADSG Guidelines: Insulin Therapy in Diabetes
    Silver, Bahendeka, Ramaiya, Kaushik, Andrew, Swai Babu, Fredrick, Otieno, Bajaj, Sarita, Kalra, Sanjay, Charlotte, Bavuma M., Claudine, Karigire, Makhoba, Anthony · 2018 · Diabetes Therapy
95. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities
    Boucai, Laura, Southern, William N., Zonszein, Joel · 2011 · The American Journal of Medicine
96. Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
    Funk, Steven Daniel, Yurdagul, Arif, Orr, A. Wayne · 2012 · International Journal of Vascular Medicine
97. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets
    Mitsuo V. Kato, Rama D Natarajan · 2015 · Annals of the New York Academy of Sciences
98. Glycemic Management of Type 2 Diabetes Mellitus
    Faramarz Ismail‐Beigi · 2012 · New England Journal of Medicine
99. Diabetes mellitus and stroke: A clinical update
    Tun, Nyo Nyo, Arunagirinathan, Ganesan, Munshi, Sunil K, Pappachan, Joseph M · 2017 · World Journal of Diabetes
100. Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
     Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini · 2020 · Diabetes Metabolic Syndrome and Obesity